Murdoch Children's Research Institute, VIC
Professor Tang is a Paediatric immunologist allergist at the Royal Children’s Hospital in Melbourne, Australia; Group Leader of Allergy and Immune Disorders Research at the Murdoch Children’s Research Institute; and a Professor in the Department of Paediatrics at the University of Melbourne. She graduated from Medicine (with Honors) at The University of Melbourne in 1986, where she also attained her PhD in 1995. She went on to complete her Allergy and Immunology training through the Royal Australasian College of Physicians and Royal College of Pathologists Australasia in 1997.
Professor Tang has received national and international awards in recognition of her achievements in allergy immunology research and clinical care, including the prestigious Victorian Public Healthcare Award (Category – Most Appropriate Care), the Pharmacia International Allergy Fellowship and the American Academy of Allergy Asthma and Immunology President's Grant-in-Aid Award.
Professor Tang is a Board Director of the World Allergy Organisation. She sits on various expert committees of the American Academy of Allergy Asthma and Immunology, World Allergy Organisation and the Australasian Society of Clinical Immunology and Allergy.
Professor Tang is an internationally recognized leader in the field of allergy and immunology. She has authored more than 280 peer reviewed journal articles and book chapters and received in excess of $30M in peer-reviewed grant funding. She is an invited speaker at major international scientific meetings in the field of Allergy and Immunology including the American Academy of Allergy Asthma and Immunology (AAAAI), European Academy of Allergy Asthma and Clinical Immunology (EAACI), Asia Pacific Association of Allergy and Clinical Immunology, and World Allergy Congress (WAC).
Professor Tang is committed to improving the lives of children with allergic and immune disorders through delivering evidence based clinical care and leading cutting edge research. Her research investigates the role of the intestinal microbiota in early life immune programming with the ultimate aim of identifying new approaches to treat or prevent allergic disease. Recently, she has developed a highly effective novel treatment for food allergy that induced remission of peanut allergy in 80% of those treated. The patented probiotic food immunotherapy technology has been licensed to Prota Therapeutics, an Australian biotech start up company spun out of the Murdoch Children’s Research Institute.